# Does New Mexico Medicaid Cover Wegovy? Why Phentermine Is In and GLP-1s Are Out

By Nora Bissett, Pricing Editor (https://glpwatchdog.org/authors/nora-bissett) | Published: 2026-11-07

Canonical page: https://glpwatchdog.org/research/new-mexico-medicaid-glp1-coverage

> New Mexico runs the Medicaid pattern backward: six older diet drugs are covered with prior authorization, while Wegovy, Zepbound and Saxenda are listed as not covered, with no published heart, sleep apnea or MASH route. What Turquoise Care members should ask and how appeals work.

## Key points

- The state weight drug page puts Wegovy, Zepbound and Saxenda in its not covered column.
- Six older diet drugs, including phentermine and orlistat, are covered with prior authorization.
- Those older drugs need a BMI over 40, or over 35 with a related condition, and start with a three-month approval.
- No published route exists for Wegovy in heart disease or MASH, or Zepbound in sleep apnea; plan members should ask their plan.
- Plan appeals are due within 60 days, and the state hearing deadline on the notice should be met early.

No. As of November 2026, New Mexico Medicaid lists Wegovy, Zepbound and Saxenda as not covered, and its state rule excludes weight-loss drugs.[1][2] Unlike most states, though, it still pays for older diet drugs such as phentermine and orlistat with prior authorization, and we found no published route for Wegovy in heart disease or MASH, or for Zepbound in sleep apnea.[1]

> **About this article.** This page reads the New Mexico Health Care Authority’s weight drug page, the pharmacy rule in the state code, the statewide drug list effective October 1, 2026 and its FAQ, and the state’s appeal rules, as they stood on November 1 and 2, 2026, and rechecked on November 7, 2026. The weight drug page speaks for fee-for-service Medicaid. We could not find any Turquoise Care plan’s own criteria for Wegovy or Zepbound, so plan members should confirm with their plan. To compare states, use the [state Medicaid GLP-1 checker](https://glpwatchdog.org/tools/state-medicaid-glp1-checker).

## Does New Mexico Medicaid cover Wegovy for weight loss?

It does not. The state code names “weight loss/weight control drugs” among the pharmacy items Medicaid does not cover.[2] The Health Care Authority’s weight drug page then sorts drugs into two columns, and Wegovy, Zepbound and Saxenda sit under “Not Covered by New Mexico Medicaid,” along with Imcivree, a drug for rare genetic obesity.[1] Under federal law, any state may make this choice, since drugs used for weight loss are on a short list Medicaid may exclude.[10] Our explainer on [why Medicaid treats Ozempic and Wegovy differently](https://glpwatchdog.org/research/does-medicaid-cover-ozempic-and-wegovy) covers that federal side.

## Which weight-loss drugs does New Mexico Medicaid cover?

Six older ones, each with prior authorization: benzphetamine (Didres), phentermine (Fastin), sibutramine (Meridia), mazindol (Sanorex), phendimetrazine (Tenuate) and orlistat (Xenical).[1] That reverses a common pattern. Several states drop these drugs while opening narrow routes to Wegovy or Zepbound; New Mexico keeps the old drugs and lists the new ones as not covered.[1]

*New Mexico Medicaid weight drug rules, from the Health Care Authority page rechecked November 7, 2026*

| Item | What the page says |
| --- | --- |
| Covered with prior authorization | Benzphetamine, phentermine, sibutramine, mazindol, phendimetrazine, orlistat |
| Not covered | Wegovy, Zepbound, Saxenda, Imcivree |
| Weight threshold | BMI over 40, or over 35 with high blood pressure, diabetes or abnormal cholesterol |
| Diet and exercise | A six-month trial is recommended, not required |
| First approval | Three months |
| Orlistat renewal | One year, with at least 3% weight loss and better related conditions |
| Short-term drugs | Approval ends after three months |

The bar is high. A patient needs a BMI over 40, or over 35 with high blood pressure, diabetes or abnormal cholesterol.[1] The list is also dated in one respect: Meridia was withdrawn from the US market on December 21, 2010, after data tied sibutramine to a higher risk of heart attack and stroke.[11] Our comparison of [phentermine and a GLP-1](https://glpwatchdog.org/research/phentermine-vs-a-glp1) sets out how far apart the results are.

## Will New Mexico Medicaid pay for Wegovy for heart disease or Zepbound for sleep apnea?

Not according to anything the state has published. Wegovy’s label covers lowering heart attack and stroke risk in adults with heart disease and excess weight, and treating MASH with F2 to F3 liver scarring; Zepbound’s covers moderate to severe sleep apnea in adults with obesity.[12][13] Many states with a weight-loss exclusion still pay for those uses. New Mexico’s page lists both drugs as not covered with no exception, and we found no criteria for any of the three uses.[1]

Plan members have one open question. Turquoise Care, the state’s managed care program, runs through four plans: Blue Cross and Blue Shield of New Mexico, Molina Healthcare, Presbyterian Health Plan or UnitedHealthcare Community Plan.[6] The state’s FAQ says drugs that are not on the statewide list may still be covered and are managed by fee-for-service and by each plan.[4] We could not find any plan criteria for these uses. A patient with heart disease, MASH or sleep apnea should ask the plan, in writing, whether it has a route, and keep the answer.

## Does New Mexico Medicaid cover Ozempic for diabetes?

The state does not settle it in one place. The statewide drug list that began on July 1, 2026 covers only selected drug classes, and we found no GLP-1 or diabetes injectable class on the October 2026 version.[3][4] That leaves Ozempic, Mounjaro, Trulicity and the other diabetes GLP-1s to each plan’s own formulary.[4] The weight-loss exclusion targets the use, not the molecule, so a diabetes prescription is a separate question from Wegovy for weight.[2] Check your plan’s formulary or call member services.

The new list also changed how existing prescriptions work. A member already taking a non-preferred drug has until April 2027 before that drug needs prior authorization; a new start gets no transition.[4]

## How do you request prior authorization in New Mexico?

For the covered diet drugs, the prescriber sends Form MAD 635, the state’s drug authorization request.[1] The weight drug page says to fax it to the Medical Assistance Division at 505-827-3185, but the October 2026 drug list gives 1-833-560-0237 and the form itself prints 833-860-0237.[1][3][5] Before faxing, confirm the number with the Conduent pharmacy help desk at 1-800-365-4944, option 3.[3] Plan members use their plan’s process instead.

## How do you appeal a Medicaid drug denial in New Mexico?

Plan members appeal to the plan first, by phone or in writing, within 60 calendar days of the date the plan mailed its notice.[8] If the plan’s final decision is still no, the next step is a state administrative hearing. The state rule, last replaced in 2014, says that request is due within 30 calendar days of the plan’s decision; federal managed care rules now give at least 90.[7][9] Read the deadline on your notice, and file inside 30 days if you can. People in fee-for-service Medicaid have 90 calendar days from the notice to request a hearing.[7]

An appeal can fix a missing BMI or chart note, but it cannot create a benefit the state excludes, so a request for Wegovy or Zepbound to lose weight has little to argue.[1][2] Our guide to [prior authorization and appeals](https://glpwatchdog.org/research/glp1-prior-authorization-and-appeals) covers what to put in a file when a route does exist.

## What can you do if New Mexico Medicaid will not pay?

Self-pay is the main path, and the Zepbound copay card is not: Lilly’s terms exclude anyone enrolled in Medicaid.[14] In the prices we track, Novo Nordisk sells most Wegovy pen doses for $349 a month, and Lilly’s Zepbound runs $299 at the starting dose, $399 at 5 mg and $449 at higher doses refilled on time.[14][15] Our list of the [cheapest GLP-1 options without insurance](https://glpwatchdog.org/research/cheapest-glp1-without-insurance) compares them, and the [Medicaid coverage hub](https://glpwatchdog.org/insurance/medicaid) shows how New Mexico compares with other states.

## Frequently asked questions

### Does New Mexico Medicaid cover Wegovy?

No. As of November 2026, the Health Care Authority's weight drug page lists Wegovy as not covered by New Mexico Medicaid, and the state code excludes weight-loss drugs. We found no published route for Wegovy in heart disease or MASH.

### Does Turquoise Care cover Zepbound?

The state lists Zepbound as not covered for fee-for-service Medicaid, and we found no Turquoise Care plan criteria for it, including for sleep apnea. Drugs not on the statewide list are managed by each plan, so members should ask their plan in writing.

### Does New Mexico Medicaid cover phentermine?

Yes, with prior authorization. Phentermine is one of six older weight-loss drugs the state covers when BMI is over 40, or over 35 with high blood pressure, diabetes or abnormal cholesterol. The first approval lasts three months.

### Does New Mexico Medicaid cover Ozempic?

Diabetes GLP-1s such as Ozempic are not on the statewide drug list as of October 2026, so each Turquoise Care plan and fee-for-service manage them separately. Ozempic prescribed for weight loss falls under the state's weight-loss exclusion.

### How long do I have to appeal a Turquoise Care denial?

Sixty calendar days from the plan's notice to file a plan appeal. After the plan's final decision, New Mexico's rule says to request a state hearing within 30 days, while federal rules allow at least 90; follow the date on your notice and file early.

## References

1. New Mexico Health Care Authority Weight Reduction Medications. hca.nm.gov. 2026. https://hca.nm.gov/weight-reduction-medications
2. State of New Mexico 8.324.4 NMAC: Pharmacy services (8.324.4.14 Noncovered services or service restrictions). New Mexico State Records Center and Archives. 2026. https://www.srca.nm.gov/parts/title08/08.324.0004.html
3. New Mexico Health Care Authority Preferred Drug List, effective October 1, 2026. hca.nm.gov. 2026. https://www.hca.nm.gov/wp-content/uploads/NM_PDL-10.1.26.pdf
4. New Mexico Health Care Authority Frequently Asked Questions: Medicaid Preferred Drug List (July 27, 2026). hca.nm.gov. 2026. https://www.hca.nm.gov/wp-content/uploads/NM-PDL-FAQ_07.27.26.pdf
5. New Mexico Health Care Authority MAD 635 Drug Authorization Request Form (revised March 1, 2026). hca.nm.gov. 2026. https://www.hca.nm.gov/wp-content/uploads/MAD-635-Prior-Authorization-Form-Fax.Revised-3.1.26.pdf
6. New Mexico Health Care Authority Turquoise Care. hca.nm.gov. 2026. https://www.hca.nm.gov/turquoise-care/
7. State of New Mexico 8.352.2 NMAC: Claimant hearings (8.352.2.12 Notice, time limits). New Mexico State Records Center and Archives. 2026. https://www.srca.nm.gov/parts/title08/08.352.0002.html
8. State of New Mexico 8.308.15 NMAC: Managed care program, grievances and appeals. New Mexico State Records Center and Archives. 2026. https://www.srca.nm.gov/parts/title08/08.308.0015.html
9. Code of Federal Regulations 42 CFR §438.408: Resolution and notification of grievances and appeals. Legal Information Institute, Cornell Law School. 2026. https://www.law.cornell.edu/cfr/text/42/438.408
10. United States Code 42 U.S.C. §1396r-8: Payment for covered outpatient drugs (Social Security Act §1927). Legal Information Institute, Cornell Law School. 2026. https://www.law.cornell.edu/uscode/text/42/1396r-8
11. US Food and Drug Administration Fat Burners Zone issues voluntary nationwide recall of Zero Xtreme due to presence of undeclared sibutramine. fda.gov. 2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fat-burners-zone-issues-voluntary-nationwide-recall-zero-xtreme-due-presence-undeclared-sibutramine
12. Eli Lilly and Company ZEPBOUND (tirzepatide) injection: prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
13. Novo Nordisk WEGOVY (semaglutide) injection and tablets: prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
14. Eli Lilly and Company Zepbound savings and self-pay options, with card terms. zepbound.lilly.com. 2026. https://zepbound.lilly.com/savings
15. Novo Nordisk Wegovy savings offer. novocare.com. 2026. https://www.novocare.com/obesity/products/wegovy/savings-offer.html

---

Cite as: GLP Watchdog, Nora Bissett, "Does New Mexico Medicaid Cover Wegovy? Why Phentermine Is In and GLP-1s Are Out", published 2026-11-07. https://glpwatchdog.org/research/new-mexico-medicaid-glp1-coverage

Canonical HTML page: https://glpwatchdog.org/research/new-mexico-medicaid-glp1-coverage

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.